nodes	percent_of_prediction	percent_of_DWPC	metapath
Carboprost Tromethamine—Uterine haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.0543	0.122	CcSEcCtD
Carboprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.0409	0.0736	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—focal segmental glomerulosclerosis	0.04	0.072	CbGpPWpGaD
Carboprost Tromethamine—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.0209	0.0469	CcSEcCtD
Carboprost Tromethamine—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.019	0.0427	CcSEcCtD
Carboprost Tromethamine—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.0174	0.0392	CcSEcCtD
Carboprost Tromethamine—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.0153	0.0343	CcSEcCtD
Carboprost Tromethamine—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0147	0.0331	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.0146	0.0263	CbGpPWpGaD
Carboprost Tromethamine—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0328	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—TRPC6—focal segmental glomerulosclerosis	0.0143	0.0257	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0142	0.032	CcSEcCtD
Carboprost Tromethamine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.0141	0.0316	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.0131	0.0235	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC6—focal segmental glomerulosclerosis	0.0128	0.023	CbGpPWpGaD
Carboprost Tromethamine—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0283	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.0122	0.022	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—GNAQ—focal segmental glomerulosclerosis	0.0119	0.0215	CbGpPWpGaD
Carboprost Tromethamine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0261	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.0112	0.0202	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.0112	0.0201	CbGpPWpGaD
Carboprost Tromethamine—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0111	0.0249	CcSEcCtD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR2—focal segmental glomerulosclerosis	0.011	0.0198	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—AGTR1—focal segmental glomerulosclerosis	0.0109	0.0197	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.0109	0.0196	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—GNAQ—focal segmental glomerulosclerosis	0.0107	0.0192	CbGpPWpGaD
Carboprost Tromethamine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0232	CcSEcCtD
Carboprost Tromethamine—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0225	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00998	0.018	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—focal segmental glomerulosclerosis	0.00977	0.0176	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00961	0.0173	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00946	0.017	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR2—focal segmental glomerulosclerosis	0.00941	0.0169	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—EDN1—focal segmental glomerulosclerosis	0.00926	0.0167	CbGpPWpGaD
Carboprost Tromethamine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.02	CcSEcCtD
Carboprost Tromethamine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00884	0.0199	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00863	0.0155	CbGpPWpGaD
Carboprost Tromethamine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00855	0.0192	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00846	0.0152	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—AGTR1—focal segmental glomerulosclerosis	0.00844	0.0152	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—focal segmental glomerulosclerosis	0.00828	0.0149	CbGpPWpGaD
Carboprost Tromethamine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00814	0.0183	CcSEcCtD
Carboprost Tromethamine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00805	0.0181	CcSEcCtD
Carboprost Tromethamine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00797	0.0179	CcSEcCtD
Carboprost Tromethamine—PTGFR—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00785	0.0141	CbGpPWpGaD
Carboprost Tromethamine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00781	0.0176	CcSEcCtD
Carboprost Tromethamine—PTGER1—G alpha (q) signalling events—AGT—focal segmental glomerulosclerosis	0.00769	0.0138	CbGpPWpGaD
Carboprost Tromethamine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.00758	0.0171	CcSEcCtD
Carboprost Tromethamine—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00745	0.0168	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00739	0.0133	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00732	0.0132	CbGpPWpGaD
Carboprost Tromethamine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00724	0.0163	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGTR1—focal segmental glomerulosclerosis	0.00723	0.013	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGTR2—focal segmental glomerulosclerosis	0.00716	0.0129	CbGpPWpGaD
Carboprost Tromethamine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00716	0.0161	CcSEcCtD
Carboprost Tromethamine—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.0159	CcSEcCtD
Carboprost Tromethamine—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00706	0.0159	CcSEcCtD
Carboprost Tromethamine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00704	0.0158	CcSEcCtD
Carboprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00702	0.0126	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—focal segmental glomerulosclerosis	0.00688	0.0124	CbGpPWpGaD
Carboprost Tromethamine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.0152	CcSEcCtD
Carboprost Tromethamine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00672	0.0151	CcSEcCtD
Carboprost Tromethamine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00654	0.0147	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00627	0.0113	CbGpPWpGaD
Carboprost Tromethamine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00617	0.0139	CcSEcCtD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—focal segmental glomerulosclerosis	0.00613	0.011	CbGpPWpGaD
Carboprost Tromethamine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00608	0.0137	CcSEcCtD
Carboprost Tromethamine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00603	0.0136	CcSEcCtD
Carboprost Tromethamine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00602	0.0135	CcSEcCtD
Carboprost Tromethamine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00579	0.013	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00563	0.0101	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00551	0.00991	CbGpPWpGaD
Carboprost Tromethamine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00535	0.012	CcSEcCtD
Carboprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.0052	0.00936	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00509	0.00916	CbGpPWpGaD
Carboprost Tromethamine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00499	0.0112	CcSEcCtD
Carboprost Tromethamine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00486	0.0109	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00477	0.00859	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00467	0.00841	CbGpPWpGaD
Carboprost Tromethamine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.0104	CcSEcCtD
Carboprost Tromethamine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00448	0.0101	CcSEcCtD
Carboprost Tromethamine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.0043	0.00968	CcSEcCtD
Carboprost Tromethamine—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00427	0.0096	CcSEcCtD
Carboprost Tromethamine—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00426	0.00959	CcSEcCtD
Carboprost Tromethamine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.00954	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00416	0.00749	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00414	0.00744	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00407	0.00733	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00405	0.00729	CbGpPWpGaD
Carboprost Tromethamine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00402	0.00905	CcSEcCtD
Carboprost Tromethamine—PTGFR—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00396	0.00713	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00391	0.00703	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00388	0.00698	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00383	0.00688	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00378	0.0068	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00376	0.00676	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.0037	0.00665	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00368	0.00662	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00359	0.00646	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00352	0.00633	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00348	0.00626	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0034	0.00613	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00318	0.00572	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00316	0.00568	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00311	0.0056	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00309	0.00556	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00303	0.00546	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00297	0.00535	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00289	0.0052	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00283	0.00509	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.0027	0.00485	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00264	0.00475	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00245	0.00441	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.0024	0.00431	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00224	0.00403	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00223	0.00402	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00222	0.00399	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00219	0.00394	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00218	0.00393	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00217	0.00391	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00203	0.00366	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00199	0.00358	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00187	0.00336	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00183	0.00329	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00171	0.00307	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00167	0.00301	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00145	0.0026	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.00142	0.00255	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.0014	0.00253	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.00137	0.00247	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00133	0.00239	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.0013	0.00234	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.0012	0.00216	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00118	0.00212	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00111	0.002	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00109	0.00195	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000923	0.00166	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000904	0.00163	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000707	0.00127	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000692	0.00125	CbGpPWpGaD
Carboprost Tromethamine—PTGFR—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000583	0.00105	CbGpPWpGaD
Carboprost Tromethamine—PTGER1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.00057	0.00103	CbGpPWpGaD
